$VCYT

McGuire Annie sold $89K of VCYT

McGuire Annie (EVP, General Counsel) sold 1,776 shares of VERACYTE, INC. (VCYT) at $50.12 on 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · McGuire Annie
Published Jun 5, 2026, 1:38 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 2:02 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VCYT
Neutral
medium confidence
Mentioned
$VCYT
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VCYTNeutralLow
01

Why it matters

The disclosure updates the insider-trading record for VCYT but does not indicate any new company event (earnings, trial results, deals, or regulatory actions).

02

Market read

Primarily a sentiment/positioning datapoint; likely low incremental impact versus other catalysts.

03

What to watch

Traders may want to compare with prior Form 4 patterns (frequency/size) to judge whether this is routine or part of a broader trend.

Relevance 6/10Novelty 4/10Timing: After-hours SEC Form 4 filed for a 2026-06-04 sale

Background

SEC Form 4 disclosures report insider trades; Rule 10b5-1 plans are pre-arranged to reduce trading on material nonpublic information.

Company-level read

Ticker impact

$VCYTNeutralMedium confidence
Context

Veracyte insider (EVP, General Counsel) sold 1,776 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term price impact; may slightly affect sentiment but not a fundamental catalyst.

Evidence & confidence

The filing provides a specific sale price/size and confirms the transaction was pre-arranged under Rule 10b5-1, reducing signal strength.

Market effects

Minimal; this is company-specific insider activity with no stated operational/clinical/regulatory change.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations, so the market may ignore it.

Key entities

  • Veracyte, Inc.

    EVP, General Counsel McGuire Annie sold 1,776 shares at $50.1168/share under a pre-arranged 10b5-1 plan.

Related articles

$VCYTHigh

VERACYTE, INC. (VCYT): Results of Operations and Financial Condition

VERACYTE, INC. (VCYT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 vcyt-07x30x20268xkearnings.htm EX-99.1 Document Exhibit 99.1 Veracyte Announces Second Quarter 2026 Financial Results Grew total revenue to $150.3 million and testing revenue to $145.7 million, representing increases of 15% and 19% year-over-year, respectively Conferenc